HIGH-VOLUME · HOSP-MID
ezetimibe Side Effects
ezetimibe (also sold as Zetia) is HIGH-VOLUME in this FAERS book #106 of 524 by FAERS report count. Signature opener: HOSP-MID - 29.6% mention hospitalization (20,751 reports).
Data updated 2026-05-15
- 70,203
- FAERS reports
FAERS voluntary reports, 2003 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
ezetimibe: 29.6% mention hospitalization (20,751 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #106 of 524 by FAERS report count.
High-report extract for ezetimibe (Zetia): 70,203 FAERS rows (2003-2025). Top named reactions: FATIGUE, NAUSEA, MYALGIA. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2003–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
FATIGUE leads 4,663 of 70,203 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (16,335 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (4,102 reports, 5.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,211 |
| DYSPNOEA | 386 |
| SEPSIS | 368 |
| FALL | 339 |
| DIARRHOEA | 331 |
| ASTHENIA | 322 |
| CARDIO-RESPIRATORY ARREST | 322 |
| FATIGUE | 315 |
| ABDOMINAL PAIN | 285 |
| HAEMORRHAGIC STROKE | 281 |
| DECREASED APPETITE | 279 |
| NAUSEA | 273 |
| DIZZINESS | 269 |
| MALAISE | 268 |
| VOMITING | 256 |
| PYREXIA | 251 |
| ALTERED STATE OF CONSCIOUSNESS | 249 |
| TACHYCARDIA | 248 |
| ARTHRALGIA | 247 |
| HEADACHE | 244 |
Reactions in Hospitalization Reports
Hospitalization mid-share (20,751, 29.6%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| NAUSEA | 1,361 |
| DYSPNOEA | 1,315 |
| FALL | 1,272 |
| FATIGUE | 1,243 |
| PNEUMONIA | 1,172 |
| ASTHENIA | 1,117 |
| ACUTE KIDNEY INJURY | 1,115 |
| DIARRHOEA | 1,058 |
| VOMITING | 1,015 |
| DIZZINESS | 981 |
| MYOCARDIAL INFARCTION | 930 |
| PAIN | 913 |
| HYPOTENSION | 888 |
| HEADACHE | 858 |
| MALAISE | 854 |
| PYREXIA | 849 |
| RHABDOMYOLYSIS | 762 |
| ANAEMIA | 729 |
| CEREBROVASCULAR ACCIDENT | 721 |
| CHEST PAIN | 717 |
How to read ezetimibe FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)
FAERS holds 70,203 voluntary reports linked to ezetimibe (Zetia), 2003-2025. Death is listed on 4,102 (5.8%). Hospitalization appears on 20,751 (29.6%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-MID is the page opener, not a per-patient risk.
Read with ezetimibe
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 70,292 FAERS cases (Δ 89 heavier vs ezetimibe); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 70,341 FAERS cases (Δ 138 heavier vs ezetimibe); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 71,900 FAERS cases (Δ 1,697 heavier vs ezetimibe); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 72,117 FAERS cases (Δ 1,914 heavier vs ezetimibe); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 56.3 pp vs ezetimibe's DEATH-HEAVY): CASELOAD · HOSP-MID.
ezetimibe stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.